The ROE as of September 2024 (TTM) for Adverum Biotechnologies, Inc. (ADVM) is -74.45%

According to Adverum Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current ROE is -74.45%. This represents a change of 250.29% compared to the average of -21.26% of the last 4 quarters.

Adverum Biotechnologies, Inc. (ADVM) Historical ROE (quarterly & annually)

How has ADVM ROE performed in the past?

The mean historical ROE of Adverum Biotechnologies, Inc. over the last ten years is -49.06%. The current -74.45% ROE has changed 51.76% with respect to the historical average. Over the past ten years (40 quarters), ADVM's ROE was at its highest in in the March 2015 quarter at -3.40%. The ROE was at its lowest in in the September 2023 quarter at -32.02%.

Adverum Biotechnologies, Inc. (ADVM) ROE by Quarter and Year

Discovering the peaks and valleys of Adverum Biotechnologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adverum Biotechnologies, Inc. (ADVM) Average ROE

How has ADVM ROE performed in the past?

The current ROE of Adverum Biotechnologies, Inc. (ADVM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adverum Biotechnologies, Inc. (ADVM) ROE vs. Peers

How is ADVM’s ROE compared to its peers?

Adverum Biotechnologies, Inc.’s ROE is greater than uniQure N.V. (-158.09%), greater than Rocket Pharmaceuticals, Inc. (-54.47%), greater than Rhythm Pharmaceuticals, Inc. (-221.66%), greater than Solid Biosciences Inc. (-53.76%), greater than MeiraGTx Holdings plc (-86.28%), greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Rezolute, Inc. (-60.90%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Passage Bio, Inc. (-70.73%), greater than Absci Corporation (-44.24%), greater than Kezar Life Sciences, Inc. (-54.50%), less than Oncternal Therapeutics, Inc. (120.03%), greater than Kodiak Sciences Inc. (-77.23%), greater than Galmed Pharmaceuticals Ltd. (-43.60%), greater than Affimed N.V. (-155.57%), greater than Mereo BioPharma Group plc (-63.39%), greater than Homology Medicines, Inc. (-100.91%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Atreca, Inc. (-195.22%), greater than TCR2 Therapeutics Inc. (-89.51%),

Build a custom stock screener for Adverum Biotechnologies, Inc. (ADVM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adverum Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adverum Biotechnologies, Inc. (ADVM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adverum Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.